Aliases & Classifications for Hyperglycemia

Summaries for Hyperglycemia

MedlinePlus : 41 hyperglycemia means high blood sugar or glucose. glucose comes from the foods you eat. insulin is a hormone that moves glucose into your cells to give them energy. hyperglycemia happens when your body doesn't make enough insulin or can't use it the right way. people with diabetes can get hyperglycemia from not eating the right foods or not taking medicines correctly. other problems that can raise blood sugar include infections, certain medicines, hormone imbalances, or severe illnesses.

MalaCards based summary : Hyperglycemia is related to diabetes mellitus, permanent neonatal and diabetes mellitus, transient neonatal, 3, and has symptoms including cachexia, cyanosis and dyspnea. An important gene associated with Hyperglycemia is INS (Insulin), and among its related pathways/superpathways are Developmental Biology and AMP-activated Protein Kinase (AMPK) Signaling. The drugs Glipizide and Metformin have been mentioned in the context of this disorder. Affiliated tissues include endothelial, heart and testes, and related phenotypes are homeostasis/metabolism and growth/size/body region

Wikipedia : 72 Hyperglycemia, or high blood sugar (also spelled hyperglycaemia or hyperglycæmia) is a condition in... more...

Related Diseases for Hyperglycemia

Diseases related to Hyperglycemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 289)
id Related Disease Score Top Affiliating Genes
1 diabetes mellitus, permanent neonatal 32.9 ABCC8 GCK
2 diabetes mellitus, transient neonatal, 3 32.4 ABCC8 KCNJ11
3 diabetic cataract 29.8 ABCC8 GCK INS INSR KCNJ11 SST
4 diabetic encephalopathy 29.6 ADIPOQ IGF1 INS LEP
5 intellectual deficit buenos-aires type 11.0 INS INSR
6 palmoplantar keratoderma and woolly hair 11.0 ABCC8 INSR
7 hyperinsulinism 11.0
8 cardiomyopathy, dilated, 1jj 10.9 GCG INS
9 diabetes mellitus, transient neonatal, 1 10.9
10 writing disorder 10.9 ABCC8 GCK KCNJ11
11 nephronophthisis 19 10.9 ABCC8 INS KCNJ11
12 achard thiers syndrome 10.9 ADIPOQ PPARG
13 mody, type ii 10.9
14 peripheral degeneration of cornea 10.9 GCG INS SST
15 prolactin producing pituitary tumor 10.9 IGF1 SST
16 selenium poisoning 10.8 IGF1 INS
17 hyperlipoproteinemia, type ib 10.8 IGF1 INS INSR
18 glomerulosclerosis, focal segmental, 1 10.8 IGF1 INS INSR
19 acute insulin response 10.8 ABCC8 GCG INS KCNJ11
20 labyrinthine unilateral reactive loss 10.8 ABCC8 GCK INS KCNJ11
21 protein s deficiency 10.8 IGF1 INS SST
22 atrial fibrillation, familial, 12 10.8 ABCC8 KCNJ11
23 idiopathic juxtafoveal retinal telangiectasia 10.8 ADIPOQ INS PPARG
24 pandas 10.8 INS SST
25 diabetes mellitus, ketosis-prone 10.8
26 mitochondrial complex iii deficiency, nuclear type 6 10.8
27 diabetes mellitus, insulin-dependent 10.8
28 diabetes and deafness, maternally inherited 10.8
29 agenesis of the dorsal pancreas 10.8
30 retinitis pigmentosa 17 10.8 AKR1B1 ALB INS
31 pelvic muscle wasting 10.7 IGF1 INS INSR
32 retinitis pigmentosa 68 10.7 ABCC8 INS SLC2A2
33 tropical sprue 10.7 GCG IGF1 SST
34 uterine ligament clear cell adenocarcinoma 10.7 IGF1 INS SST
35 male reproductive organ benign neoplasm 10.7 IGF1 INS SST
36 cervical keratinizing squamous cell carcinoma 10.7 INS SST
37 fissured tongue 10.7 AKR1B1 ALB INS
38 hyperinsulinemic hypoglycemia, familial, 4 10.7 ADIPOQ GCK INS PPARG
39 intestinal volvulus 10.7 INS SST
40 hyperchylomicronemia, late-onset 10.7 ADIPOQ INS INSR
41 mononeuritis of upper limb and mononeuritis multiplex 10.7 IGF1 SST
42 tuberculum sellae meningioma 10.6 ALB GCG INS SST
43 diabetes mellitus, insulin-dependent, 19 10.6
44 diabetes mellitus, insulin-dependent, 12 10.6
45 diabetes mellitus, insulin-dependent, 22 10.6
46 megalencephaly-capillary malformation-polymicrogyria syndrome, somatic 10.6
47 diabetes, mellitus, insulin-dependent 10 10.6
48 histiocytosis-lymphadenopathy plus syndrome 10.6
49 cataract 47, juvenile, with microcornea 10.6
50 diabetes mellitus, insulin-dependent, 2 10.6

Graphical network of the top 20 diseases related to Hyperglycemia:



Diseases related to Hyperglycemia

Symptoms & Phenotypes for Hyperglycemia

UMLS symptoms related to Hyperglycemia:


cachexia, cyanosis, dyspnea, edema, fever, headache, icterus, seizures, signs and symptoms, signs and symptoms, digestive, syncope, vertigo, hot flushes, symptoms

MGI Mouse Phenotypes related to Hyperglycemia:

44 (show all 13)
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.39 ABCC8 ADIPOQ AKR1B1 ALB DPP4 GCK
2 growth/size/body region MP:0005378 10.36 PPARG SLC2A2 SLC5A2 SST GCK HNF1A
3 endocrine/exocrine gland MP:0005379 10.32 ABCC8 ADIPOQ ALB DPP4 GCK HNF1A
4 behavior/neurological MP:0005386 10.29 UNC13B ADIPOQ AKR1B1 HNF1A INS INSR
5 mortality/aging MP:0010768 10.2 INSR KCNJ11 LEP PDX1 PPARG SLC2A2
6 adipose tissue MP:0005375 10.18 ADIPOQ HNF1A IGF1 INS INSR KCNJ11
7 liver/biliary system MP:0005370 10.07 ADIPOQ ALB GCK HNF1A INS INSR
8 digestive/alimentary MP:0005381 10.04 ALB HNF1A INS INSR LEP PDX1
9 integument MP:0010771 10.01 ADIPOQ HNF1A IGF1 INS KCNJ11 LEP
10 muscle MP:0005369 10 PDX1 PPARG SLC2A2 ADIPOQ ALB HNF1A
11 no phenotypic analysis MP:0003012 9.81 ABCC8 HNF1A INS KCNJ11 PDX1 PPARG
12 renal/urinary system MP:0005367 9.73 AKR1B1 ALB GCK HNF1A IGF1 INS
13 skeleton MP:0005390 9.32 ADIPOQ AKR1B1 HNF1A IAPP IGF1 INS

Drugs & Therapeutics for Hyperglycemia

Drugs for Hyperglycemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 698)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Glipizide Approved Phase 4,Phase 3,Phase 2,Phase 1 29094-61-9 3478
2
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 657-24-9 14219 4091
3
Saxagliptin Approved Phase 4,Phase 3,Phase 2 361442-04-8 11243969
4
Zinc Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 7440-66-6 32051 23994
5
Aripiprazole Approved, Investigational Phase 4,Phase 3 129722-12-9 60795
6
Insulin Detemir Approved Phase 4,Phase 3,Phase 2 169148-63-4 5311023
7
Insulin-glulisine Approved Phase 4,Phase 3,Phase 2 207748-29-6
8
Insulin Aspart Approved Phase 4,Phase 3,Phase 2,Phase 1 116094-23-6 16132418
9
Insulin Lispro Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 133107-64-9
10
Febuxostat Approved Phase 4 144060-53-7 134018
11
Nitric Oxide Approved Phase 4 10102-43-9 145068
12
Nitroglycerin Approved, Investigational Phase 4 55-63-0 4510
13
Acarbose Approved, Investigational Phase 4,Phase 3,Phase 2 56180-94-0 441184
14
Exenatide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 141758-74-9 15991534
15
Aspirin Approved, Vet_approved Phase 4,Phase 3 50-78-2 2244
16
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
17 Parecoxib Approved Phase 4 198470-84-7
18
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
19
Insulin Glargine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 160337-95-1
20
Isosorbide Dinitrate Approved Phase 4 87-33-2 6883
21
Amlodipine Approved Phase 4 88150-42-9 2162
22
Atenolol Approved Phase 4 29122-68-7 2249
23
Clonidine Approved Phase 4 4205-90-7 2803
24
Doxazosin Approved Phase 4 74191-85-8 3157
25
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440
26
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3,Phase 2 58-93-5 3639
27
Irbesartan Approved, Investigational Phase 4 138402-11-6 3749
28
Ramipril Approved Phase 4,Phase 3 87333-19-5 5362129
29
Simvastatin Approved Phase 4,Phase 3,Phase 2 79902-63-9 54454
30
Nateglinide Approved, Investigational Phase 4 105816-04-4 60026
31
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
32
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-23-7 5754 657311
33
Moxonidine Approved Phase 4 75438-57-2 4810
34
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
35
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
36
Rosiglitazone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 122320-73-4 77999
37
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 53-03-2 5865
38
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
39
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-02-2 5743
40
Pramlintide Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 151126-32-8
41
Menthol Approved Phase 4,Phase 3 2216-51-5 16666
42
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
43 Racepinephrine Approved Phase 4,Phase 3,Phase 2
44
Fenofibrate Approved Phase 4,Phase 2,Phase 3 49562-28-9 3339
45
Linagliptin Approved Phase 4,Phase 3 668270-12-0 10096344
46
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2 111025-46-8 4829
47
Voglibose Approved, Investigational Phase 4 83480-29-9 444020
48
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1 64-17-5 702
49
Liraglutide Approved Phase 4,Phase 3,Phase 2,Phase 1 204656-20-2 44147092
50
Copper Approved Phase 4 7440-50-8 27099

Interventional clinical trials:

(show top 50) (show all 1643)

id Name Status NCT ID Phase Drugs
1 Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia Unknown status NCT01267448 Phase 4 Glipizide XL;Saxagliptin + Metformin XR;Metformin XR
2 Intensive Versus Nonintensive Insulin Therapy for Hyperglycemia After Traumatic Brain Injury Unknown status NCT02161055 Phase 4 Insulin
3 Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia Unknown status NCT00541554 Phase 4 Abilify (aripiprazole)
4 Arterial Catheter to Monitor Glycemia Unknown status NCT01176279 Phase 4
5 Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes Unknown status NCT02048189 Phase 4 LEVEMIR;APIDRA
6 A Trial Comparing SGC and Conventional Empiric Treatment for Glucose Control in Critically Ill Patients With Mechanical Ventilation in ICU Unknown status NCT02491346 Phase 4
7 CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) Unknown status NCT01848990 Phase 4 Commercial Hylenex® recombinant (hyaluronidase human injection);Precommercial Hylenex recombinant (hyaluronidase human injection);Insulin lispro;Insulin aspart;Insulin glulisine
8 The Effect of Uric Acid Lowering in Type 1 Diabetes Unknown status NCT02344602 Phase 4 Febuxostat
9 Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial) Unknown status NCT00858676 Phase 4 acarbose
10 Obtain a Good Blood Glucose Control With the Paradigm Real Time System Unknown status NCT00441129 Phase 4
11 The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients Unknown status NCT01270191 Phase 4 Exenatide;Humulin-N
12 Curcumin for Type 2 Diabetic Patients Unknown status NCT01052597 Phase 4 curcumin
13 Type 2 Diabetes Mellitus and Atherosclerosis Unknown status NCT01250340 Phase 4 Aspirin;Placebo
14 Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance After Gastrointestinal Laparoscopic Surgery Unknown status NCT01930318 Phase 4 parecoxib
15 Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus Unknown status NCT00446810 Phase 4 Benfotiamine;Placebo
16 Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial Unknown status NCT01143948 Phase 4 Glargine & Glulisine;Regular insulin;NPH & regular insulin
17 Influence of Nitrates on Bone Remodeling and Endothelial Function in Patients With Type 2 Diabetes Mellitus Unknown status NCT02011620 Phase 4
18 Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes. Unknown status NCT00254085 Phase 4 Insulin Aspart
19 Nephropathy In Type 2 Diabetes and Cardio-renal Events Unknown status NCT00535925 Phase 4 current therapy;irbesartan;ramipril;hydrochlorothiazide;furosemide;amlodipine;atenolol;doxazosin;clonidine;insulin;simvastatin;fibrate;erythropoietin;aspirin
20 Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference? Unknown status NCT00259168 Phase 4 Nateglinide
21 Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics Unknown status NCT01095822 Phase 4 Aliskiren + Valsartan
22 Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose Unknown status NCT00145353 Phase 4 Insulin NovoRapid versus Actrapid
23 Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes Unknown status NCT01758471 Phase 4 Glipizide;Acarbose
24 Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity Unknown status NCT01180231 Phase 4 Moxonidine (Physiotens)
25 Bone Turnover in Type 2 Diabetes Patients Unknown status NCT00732121 Phase 4 Sitagliptin;Placebo
26 TReatment by Insulin Continuous Infusion in Type 2 DIAbetes Unknown status NCT01889914 Phase 4 2 different procedures of administration of insulin
27 6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome Unknown status NCT00127985 Phase 4 6-methyl-prednisolone
28 Intensity of Exercise and Glucose Metabolism Unknown status NCT01649219 Phase 4
29 Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance Unknown status NCT01052025 Phase 4 Curcumin
30 Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance Unknown status NCT00733174 Phase 4 Rosiglitazone;Placebo
31 Effect of Saxagliptin on Pre-Diabetes Mellitus and Obesity Unknown status NCT01960205 Phase 4 Saxagliptin;saxagliptin;metformin
32 Hyperglycemia and Effects of Daily 100 mg Versus 200 mg of Hydrocortisone Therapy in Patients With Septic Shock Completed NCT02266264 Phase 4 Hydrocortisone
33 Glucose Control for Glucocorticoid Induced Hyperglycemia During Chemotherapy Completed NCT02155374 Phase 4 Sliding scale insulin;Intermediate acting insulin;Glucose lowering medication;Chemotherapy
34 Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia Completed NCT01184014 Phase 4 NPH insulin plus Complete Insulin Orders;Complete Insulin Orders
35 NPH and Regular Insulin in the Treatment of Inpatient Hyperglycemia: Comparison of 3 Basal-bolus Regimens Completed NCT02758522 Phase 4 Once-daily Insulin;Twice-daily Insulin;Triple-daily Insulin
36 The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients Completed NCT01810952 Phase 4 Glargine insulin;Lispro insulin;NPH Insulin
37 Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery Completed NCT02443402 Phase 4 Sitagliptin;Placebo;Regular Human Insulin;Insulin glargine;Supplemental insulin (Insulin lispro);Supplemental insulin (Insulin aspart)
38 Intensive Insulin Therapy in Non-diabetic Patients With Acute Myocardial Infarction and Hyperglycaemia Completed NCT00362778 Phase 4 Insulin
39 Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery Completed NCT01545700 Phase 4 Control-saline;Dexamethasone 4 mg;Dexamethasone 8 mg;Control saline;Dexamethasone 4 mg;Dexamethasone 8 mg
40 Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes Completed NCT00191282 Phase 4 Insulin lispro;Human insulin isophane suspension (NPH);Insulin glargine;Human insulin isophane suspension;Human insulin 30/70
41 Study of a Model-based Approach to Blood Glucose Control in Very-low-birthweight Neonates Completed NCT01419873 Phase 4 Actrapid Human Insulin
42 A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes Completed NCT01159938 Phase 4 Lispro
43 Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia Completed NCT01269047 Phase 4 Pramlintide;Exenatide;Insulin
44 Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM) Completed NCT00771693 Phase 4 Insulin aspart (Novorapid®)
45 Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation Completed NCT00779701 Phase 4 Insulin
46 Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings Completed NCT00177398 Phase 4 Glargine insulin vs regular insulin
47 Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (DM) Completed NCT00979628 Phase 4 sliding scale regular insulin (SSRI);Basal Bolus;Basal Plus
48 Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery Completed NCT00596687 Phase 4 Insulin glargine;Regular insulin;Insulin glulisine
49 DPP4 Inhibitor in the Hospital Completed NCT01378117 Phase 4 Sitagliptin;glargine;lispro
50 Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes Completed NCT00394407 Phase 4 sliding scale regular insulin;glargine basal insulin and glulisine prandial insulin

Search NIH Clinical Center for Hyperglycemia

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: hyperglycemia

Genetic Tests for Hyperglycemia

Genetic tests related to Hyperglycemia:

id Genetic test Affiliating Genes
1 Hyperglycemia 29

Anatomical Context for Hyperglycemia

MalaCards organs/tissues related to Hyperglycemia:

39
Endothelial, Heart, Testes, Liver, Brain, Pancreas, Bone

Publications for Hyperglycemia

Articles related to Hyperglycemia:

(show top 50) (show all 1273)
id Title Authors Year
1
Hyperglycemia decreases preoxiredoxin-2 expression in a middle cerebral artery occlusion model. ( 28747974 )
2017
2
Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: subgroup analysis of a randomized clinical trial. ( 28921919 )
2017
3
The impact of hyperglycemia and hyperlipidemia on plasma P-selectin and platelet markers after ischemic stroke. ( 28883845 )
2017
4
Duodenal sodium/glucose co-transporter 1 expression under fasting conditions is associated with post-load hyperglycemia. ( 28938485 )
2017
5
Peppermint essential oil alleviates hyperglycemia caused by streptozotocin- nicotinamide-induced type 2 diabetes in rats. ( 28922713 )
2017
6
The study on the effect of hyperglycemia on offspring fatty tissue metabolism during pregnancy. ( 28925477 )
2017
7
Atypical presentation of central pontine myelinolysis in hyperglycemia. ( 28924482 )
2017
8
Diagnostic protocol for gestational diabetes mellitus (GDM) (IADPSG/ADA, 2011): influence on the occurrence of GDM and mild gestational hyperglycemia (MGH) and on the perinatal outcomes. ( 28053673 )
2017
9
Hyperglycemia aggravates decreases of PEA-15 and its two phosphorylated forms in cerebral ischemia. ( 28216548 )
2017
10
Hyperglycemia on admission and hospitalization outcomes in patients with atrial fibrillation. ( 28898432 )
2017
11
Cinnamaldehyde potentially attenuates gestational hyperglycemia in rats through modulation of PPARI^, proinflammatory cytokines and oxidative stress. ( 28092845 )
2017
12
Hyperglycemia in acute ischemic stroke: Is it time to re-evaluate our understanding? ( 28915969 )
2017
13
Drugs and hyperglycemia: A practical guide. ( 28923179 )
2017
14
Averrhoa bilimbi fruits attenuate hyperglycemia-mediated oxidative stress in streptozotocin-induced diabetic rats. ( 28911678 )
2017
15
Intrauterine hyperglycemia-induced inflammatory signalling via the receptor for advanced glycation end products in the cardiac muscle of the infants of diabetic mother rats. ( 28942514 )
2017
16
Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17years after the diagnosis of diabetes - A retrospective observational nation-wide cohort study. ( 28888147 )
2017
17
Stress induced hyperglycemia after spontaneous subarachnoid hemorrhage and its role in predicting cerebrospinal fluid diversion. ( 28089808 )
2017
18
Stress hyperglycemia and acute ischemic stroke in-hospital outcome. ( 28081783 )
2017
19
Thioredoxin is implicated in the antia89apoptotic effects of grape seed proanthocyanidin extract during hyperglycemia. ( 28944891 )
2017
20
Prevalence, predictors, and outcomes of steroid-induced hyperglycemia in hospitalized patients with hematologic malignancies. ( 28058528 )
2017
21
Transcription factor SP1 mediates hyperglycemia-induced upregulation of roundabout4 in retinal microvascular endothelial cells. ( 28341181 )
2017
22
Aldose Reductase Mediates NLRP3 Inflammasome- Initiated Innate Immune Response in Hyperglycemia-Induced Thp1 Monocytes and Male Mice. ( 28938395 )
2017
23
Paternal hyperglycemia in rats exacerbates the development of obesity in offspring. ( 28533422 )
2017
24
Histone Deacetylase Inhibition Ameliorates Hypertension and Hyperglycemia in a model of Cushing's Syndrome. ( 28928236 )
2017
25
Glucose-induced Changes in Gene Expression in Human Pancreatic Islets - Causes or Consequences of Chronic Hyperglycemia. ( 28882899 )
2017
26
Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes. ( 28903400 )
2017
27
NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway. ( 28411267 )
2017
28
Glycosuria and hyperglycemia in the neonatal period as the first clinical sign of Fanconi-Bickel syndrome. ( 28493372 )
2017
29
Oral Corticosterone Administration Reduces Insulitis but Promotes Insulin Resistance and Hyperglycemia in Male Nonobese Diabetic Mice. ( 28061324 )
2017
30
Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention. ( 28056793 )
2017
31
Synergistic Effect of Hyperglycemia and Helicobacterpylori Infection Status on Colorectal Adenoma Risk. ( 28475740 )
2017
32
Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia. ( 28042546 )
2017
33
Thioredoxin 2 Offers Protection against Mitochondrial Oxidative Stress in H9c2 Cells and against Myocardial Hypertrophy Induced by Hyperglycemia. ( 28914755 )
2017
34
Hyperglycemia reduces PP2A subunit B expression in a middle cerebral artery occlusion animal model. ( 28652527 )
2017
35
Urine Albumin Excretion as a Marker of Acute Glycemic Changes in Isolated Postprandial Hyperglycemia. ( 28042215 )
2017
36
Long-term Hyperglycemia Naturally Induces Dental Caries But Not Periodontal Disease in Type-1 and Type-2 Diabetic Rodents. ( 28793985 )
2017
37
Hyperglycemia as a Prognosis Predictor of Length of Stay and Functional Outcomes in Patients with Acute Ischemic Stroke. ( 28074658 )
2017
38
Diffuse (18)F-FDG accumulation in the subarachnoid space detected by PET/CT in a patient with subarachnoid hemorrhage and hyperglycemia. ( 28064344 )
2017
39
MiR-29c/PRKCI Regulates Axonal Growth of Dorsal Root Ganglia Neurons Under Hyperglycemia. ( 28070856 )
2017
40
Hyperglycemia-related advanced glycation end-products is associated with the altered phosphatidylcholine metabolism in osteoarthritis patients with diabetes. ( 28898260 )
2017
41
Diabetic Hemichorea-hemiballism after Prompt Improvement in Hyperglycemia. ( 28943546 )
2017
42
Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity. ( 28069641 )
2017
43
The Aqueous Extract of Portulaca Oleracea Ameliorates Neurobehavioral Dysfunction and Hyperglycemia Related to Streptozotocin-Diabetes Induced in Ovariectomized Rats. ( 27642327 )
2016
44
Galangin, a dietary flavonoid, improves antioxidant status and reduces hyperglycemia-mediated oxidative stress in streptozotocin-induced diabetic rats. ( 28030991 )
2016
45
Hyperglycemia and Advanced Glycation End Products Regulate miR-126 Expression in Endothelial Progenitor Cells. ( 27673690 )
2016
46
Periodontal Pocket Depth, Hyperglycemia, and Progression of Chronic Kidney Disease: A Population-Based Longitudinal Study. ( 27615146 )
2016
47
Transgenerational Glucose Intolerance of Tumor Necrosis Factor with Epigenetic Alteration in Rat Perirenal Adipose Tissue Induced by Intrauterine Hyperglycemia. ( 26881249 )
2016
48
Hyperglycemia during the immediate period following liver transplantation. ( 28031946 )
2016
49
Hyperglycemia in Stroke Impairs Polarization of Monocytes/Macrophages to a Protective Noninflammatory Cell Type. ( 27605608 )
2016
50
Hyperglycemia is associated with poor survival in primary central nervous system lymphoma patients. ( 28058711 )
2016

Variations for Hyperglycemia

Copy number variations for Hyperglycemia from CNVD:

7
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 44162 10 52900000 70600000 Copy number TFAM Hyperglycemia

Expression for Hyperglycemia

Search GEO for disease gene expression data for Hyperglycemia.

Pathways for Hyperglycemia

Pathways related to Hyperglycemia according to GeneCards Suite gene sharing:

(show all 26)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.42 ADIPOQ GCK HNF1A IAPP INS LEP
2
Show member pathways
12.39 ADIPOQ IGF1 INS INSR LEP PPARG
3
Show member pathways
12.38 GCK INS LEP SLC2A2
4 12.33 ADIPOQ GCG HNF1A INS INSR PDX1
5
Show member pathways
12.32 ABCC8 ADIPOQ GCG INS KCNJ11 SLC2A2
6
Show member pathways
12.19 DPP4 GCG IGF1 INS LEP
7
Show member pathways
12.16 ABCC8 ALB GCG GCK INS KCNJ11
8
Show member pathways
12.1 ADIPOQ IGF1 INS INSR PPARG
9 12.04 ALB IGF1 INS PDX1 SLC2A2
10 12 ADIPOQ HNF1A IGF1 INS LEP PPARG
11
Show member pathways
11.94 GCK HNF1A INS INSR PDX1 SLC2A2
12 11.84 ADIPOQ IGF1 INS LEP PPARG
13 11.82 GCG GCK SLC2A2
14
Show member pathways
11.8 GCK HNF1A IAPP INS PDX1 SLC2A2
15
Show member pathways
11.79 GCK SLC2A2 SLC5A2
16 11.78 IGF1 INS INSR
17
Show member pathways
11.59 ABCC8 ADIPOQ GCK HNF1A INS INSR
18
Show member pathways
11.52 DPP4 GCG LEP
19 11.48 ABCC8 KCNJ11 LEP